FDA inspection
GlaxoSmithKline Consumer Healthcare Holdings LLC: FDA inspection ending Oct 14, 2004
FDA inspection 352067 · No Action Indicated (NAI) · Saint Louis, MO
Key facts
| Inspection ID | 352067 |
|---|---|
| Firm | GlaxoSmithKline Consumer Healthcare Holdings LLC |
| FEI number | 1940882 |
| Address | 320 S Broadway |
| City | Saint Louis |
| State | MO |
| ZIP | 63102-2800 |
| Fiscal year | 2005 |
| Inspection end date | Oct 14, 2004 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data